BMP6 antibody (N-Term)
Quick Overview for BMP6 antibody (N-Term) (ABIN929061)
Target
See all BMP6 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Purified
-
Immunogen
- BMP6 antibody was raised in rabbit using the N terminal of BMP6 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
BMP6 Blocking Peptide, (ABIN937336), is also available for use as a blocking control in assays to test for specificity of this BMP6 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BMP6 (Bone Morphogenetic Protein 6 (BMP6))
-
Alternative Name
- BMP6
-
Background
- The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, the BMP encoded by this gene has a proposed role in early development. In addition, the fact that this BMP is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity. Synonyms: Polyclonal BMP6 antibody, Anti-BMP6 antibody, bone morphogenetic protein 6 antibody, VGR antibody, VGR1 antibody.
-
Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process
Target
-